{"title":"CeO2/g-C3N4 photoactive nanozyme-based colorimetric immunoassay for carcinoembryonic antigen detection","authors":"Yan Cheng, Yunzhi Wang, Pengcheng Zhang, Xing Hu, Xiaolin Hou, Bing Zhang","doi":"10.1007/s00604-025-07524-z","DOIUrl":null,"url":null,"abstract":"<div><p>Enzyme-mimicking nanomaterials have gained significant attention for use in colorimetric immunoassays. However, further enhancing their mimetic enzyme activity remains crucial for improving assay sensitivity. In this study, CeO<sub>2</sub>/g-C<sub>3</sub>N<sub>4</sub> nanozymes were synthesized with enhanced catalytic activity when exposed to visible light. The irradiation facilitates electron transfer within the CeO<sub>2</sub>/g-C<sub>3</sub>N<sub>4</sub> nanomaterials, leading to the generation of reactive oxygen species (ROS). These ROS then promote the oxidation of 3,3',5,5'-tetramethylbenzidine (TMB), causing a distinct color change. Based on this, a novel colorimetric immunoassay platform was developed, using the CeO<sub>2</sub>/g-C<sub>3</sub>N<sub>4</sub> nanomaterials as labels. Under visible light, the color development signal was significant amplified, resulting in improved sensitivity. This approach showed a linear response for the detection of carcinoembryonic antigen (CEA) in the range 0.5–30 ng/mL, with a limit of detection (LOD) of 0.13 ng/mL. The assay also demonstrated high specificity and excellent reproducibility. Consequently, this method offers a promising strategy for early cancer diagnosis and holds considerable potential for wider clinical applications.</p><h3>Graphical Abstract</h3>\n<div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":705,"journal":{"name":"Microchimica Acta","volume":"192 10","pages":""},"PeriodicalIF":5.3000,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microchimica Acta","FirstCategoryId":"92","ListUrlMain":"https://link.springer.com/article/10.1007/s00604-025-07524-z","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Enzyme-mimicking nanomaterials have gained significant attention for use in colorimetric immunoassays. However, further enhancing their mimetic enzyme activity remains crucial for improving assay sensitivity. In this study, CeO2/g-C3N4 nanozymes were synthesized with enhanced catalytic activity when exposed to visible light. The irradiation facilitates electron transfer within the CeO2/g-C3N4 nanomaterials, leading to the generation of reactive oxygen species (ROS). These ROS then promote the oxidation of 3,3',5,5'-tetramethylbenzidine (TMB), causing a distinct color change. Based on this, a novel colorimetric immunoassay platform was developed, using the CeO2/g-C3N4 nanomaterials as labels. Under visible light, the color development signal was significant amplified, resulting in improved sensitivity. This approach showed a linear response for the detection of carcinoembryonic antigen (CEA) in the range 0.5–30 ng/mL, with a limit of detection (LOD) of 0.13 ng/mL. The assay also demonstrated high specificity and excellent reproducibility. Consequently, this method offers a promising strategy for early cancer diagnosis and holds considerable potential for wider clinical applications.
期刊介绍:
As a peer-reviewed journal for analytical sciences and technologies on the micro- and nanoscale, Microchimica Acta has established itself as a premier forum for truly novel approaches in chemical and biochemical analysis. Coverage includes methods and devices that provide expedient solutions to the most contemporary demands in this area. Examples are point-of-care technologies, wearable (bio)sensors, in-vivo-monitoring, micro/nanomotors and materials based on synthetic biology as well as biomedical imaging and targeting.